PHASE-3 STUDIES WITH ETOPOSIDE (VP16-213) IN LUNG-CANCER PATIENTS

被引：0
作者：
ISSELL, BF [1 ]
ROSENBAUM, PF [1 ]
DHAFIR, RA [1 ]
机构：
[1] BRISTOL MYERS CO LABS,SYRACUSE,NY 13201
来源：
CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1982年 / 7卷 / 2-3期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：239 / 239
页数：1
相关论文
共 50 条
  • [21] THE ROLE OF VP16-213 (ETOPOSIDE, NSC-141540) IN GESTATIONAL CHORIOCARCINOMA
    NEWLANDS, ES
    BAGSHAWE, KD
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 7 (2-3) : 211 - 214
  • [22] PHASE-II STUDY OF VP16-213 (ETOPOSIDE) IN REFRACTORY METASTATIC BREAST-CARCINOMA
    SCHELL, FC
    YAP, HY
    HORTOBAGYI, GN
    ISSELL, B
    ESPARZA, L
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 7 (2-3) : 223 - 225
  • [23] TREATMENT OF BRAIN METASTASES OF LUNG-CANCER WITH HIGH-DOSES OF ETOPOSIDE (VP16-213) - COOPERATIVE STUDY FROM THE GROUPE FRANCAIS PNEUMO-CANCEROLOGIE
    KLEISBAUER, JP
    VESCO, D
    OREHEK, J
    BLAIVE, B
    CLARY, C
    POIRIER, R
    SARETTO, S
    CARLES, P
    DONGAY, G
    GUERIN, JC
    MARTINAT, Y
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (02): : 131 - &
  • [24] A PHASE-II STUDY OF VP16-213 (ETOPOSIDE) IN REFRACTORY METASTATIC BREAST-CARCINOMA
    SCHELL, FC
    YAP, HY
    BLUMENSCHEIN, GR
    ESPARZA, L
    ISSELL, B
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 7 (2-3) : 243 - 243
  • [25] CARBOPLATIN (CBDCA, JM8 VP16-213 IN PREVIOUSLY UNTREATED PATIENTS WITH SMALL-CELL LUNG-CANCER (SCLC)
    BISHOP, JF
    STUARTHARRIS, R
    RAGHAVAN, D
    OLVER, I
    BALL, D
    MORSTYN, G
    ARONEY, R
    HILLCOAT, B
    FOX, R
    KEFFORD, R
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1986, 16 (04): : 621 - 621
  • [26] ADRIAMYCIN, CYCLOPHOSPHAMIDE, AND ETOPOSIDE (VP-16-213) IN EXTENSIVE-STAGE SMALL CELL LUNG-CANCER
    MATELSKI, HW
    LOKICH, JJ
    HUBERMAN, MS
    ZIPOLI, TE
    PAUL, S
    SONNEBORN, H
    PHILIPS, D
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1984, 7 (06): : 729 - 732
  • [27] PHASE-2 STUDY OF HIGH-DOSE ETOPOSIDE (VP16-213) IN HEPATOCELLULAR-CARCINOMA
    SHIU, W
    MOK, SD
    LEUNG, N
    LI, M
    ZACHARIA, A
    LI, A
    MARTIN, C
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1987, 17 (02) : 113 - 115
  • [28] A PHASE-II EVALUATION OF VP16-213 IN ADVANCED OVARIAN-CANCER
    HILLCOAT, B
    BISHOP, J
    CAMPBELL, J
    MEDICAL AND PEDIATRIC ONCOLOGY, 1983, 11 (03): : 215 - 215
  • [29] VP 16-213 (VP16) AND CYCLOPHOSPHAMIDE IN THE TREATMENT OF PRIMITIVE LUNG-CANCER IN PHASE-M-1
    ESTAPE, J
    MILLA, A
    AGUSTI, A
    LLORET, JS
    PALACIN, A
    SORIANO, E
    CANCER, 1979, 43 (01) : 72 - 77
  • [30] VP16-213 PHASE-II STUDY SMALL CELL LUNG-CARCINOMA
    LARRIBA, JLG
    CARCIA, JMM
    GALLEGO, AO
    ALONSO, SJ
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 7 (2-3) : 239 - 240
12345